Landscape of transarterial chemoembolization represented interventional therapy for hepatocellular carcinoma  

作　　者：Yang-Yang Fu Wen-Mao Li Hong-Qiao Cai Yan Jiao 

机构地区：[1]Department of The First Operation Room,The First Hospital of Jilin University,Changchun 130000,Jilin Province,China [2]Department of Rehabilitation,The Second Hospital of Jilin University,Changchun 130000,Jilin Province,China [3]Department of Hepatobiliary and Pancreatic Surgery,General Surgery Center,The First Hospital of Jilin University,Changchun 130021,Jilin Province,China

出　　处：《World Journal of Gastrointestinal Surgery》2024年第12期3903-3906,共4页世界胃肠外科杂志（英文）

摘　　要：This article discusses the article written by Tan et al.Transarterial chemoembol-ization(TACE)is one of the main treatment methods for advanced hepatocellular carcinoma(HCC).There are other vascular interventional therapies,including drug-eluting bead TACE,transarterial radioembolization,and hepatic arterial infusion chemotherapy.TACE combined with anti-angiogenesis therapy may improve tumor control and prolong progression free survival.The combination therapy of TACE and immunotherapy may improve the clinical efficacy of HCC.In future research,more basic and clinical studies are needed to explore the immunogenic intervention therapy.

关 键 词：Transarterial chemoembolization Interventional therapy Hepatocellular carcinoma ANTI-ANGIOGENESIS IMMUNOTHERAPY Programmed cell death 1 

分 类 号：R735.7[医药卫生—肿瘤]